Join
Live feed
·
INSIDERFilingvia Quantisnow
Zevra Therapeutics Inc. logo

CCO Schafer Joshua sold $29,800 worth of shares (3,375 units at $8.83) and converted options into 46,667 shares, increasing direct ownership by 147% to 72,778 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZVRA (Zevra Therapeutics Inc.) and more on Quantisnow.